entrectinib

Entrectinib is a targeted cancer medication designed to block specific proteins called TRK, ROS1, and ALK that can drive tumor growth. By inhibiting these proteins, entrectinib can slow or stop the progression of certain types of cancers, such as some lung and nerve tumors. It works selectively, impacting cancer cells while generally sparing healthy cells, which can lead to fewer side effects compared to traditional chemotherapy. Entrectinib is taken orally and is typically used when cancer tests show these specific genetic alterations.